Progress and prospects for herpesvirus vaccination using gB antigens
The success of vaccines against varicella zoster virus (VZV) demonstrates the feasibility of high-level efficacy against clinical consequences of herpesvirus infection, but there is a need for new vaccines against others – in particular Epstein-Barr Virus (EBV), human cytomegalovirus (HCMV) and herp...
Gorde:
| Egile Nagusiak: | , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Frontiers Media S.A.
2026-05-01
|
| Saila: | Frontiers in Immunology |
| Gaiak: | |
| Sarrera elektronikoa: | https://www.frontiersin.org/articles/10.3389/fimmu.2026.1827628/full |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|